{"schema_version":"secwatch.filing_event.v1","accession":"0000072331-25-000030","form_type":"8-K","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.193978+00:00","generated_at":"2026-05-26T12:40:43.691997+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nordson Q1 sales down 2.8% to $615M; adjusted EPS $2.06, backlog up 15%","bullets":["Q1 GAAP EPS $1.65 vs $1.90 prior year; adjusted EPS $2.06 (down 7% YoY).","Organic sales down 9%; acquisition impact added 8%; currency headwind 2%.","Medical & Fluid Solutions sales +21% (Atrion acquisition), but organic down 11%.","Q2 guidance: sales $650-690M; adjusted EPS $2.30-$2.50.","Backlog grew ~$85M to $670M; order entry accelerated through quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0000072331-25-000030","json":"https://secwatch.observer/filing/0000072331-25-000030.json","markdown":"https://secwatch.observer/filing/0000072331-25-000030.md","text":"https://secwatch.observer/filing/0000072331-25-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000030/0000072331-25-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000030/ndsn-20250219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:40:43.691997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}